glp-1-based therapy GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1-based therapies for type 2

With the International Testing Agency (ITA) overseeing anti-doping operations at Milano Cortina 2026, the scrutiny on supplement use has intensified

Storage and Transportation in the UK Transporting your gear to the site requires more than just a rifle bag

The gold-standard for diagnosing gout is identification of intracellular monosodium urate crystals with polarising light microscopy in aspirated fluid from the affected joint

A notable proportion of patients achieve clinically significant weight loss, with studies indicating that around 40% of adults lost at least 5% of their body weight after one year, and over 15% lost at least 10%

Solithromycins longer alkyl-aryl side chains improve its binding to the ribosome, enhancing its effectiveness against macrolide-resistant strains